Avidity maturation of memory CD8 T cells is limited by self-antigen expression by Turner, Michael J. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 205 No. 8  1859-1868
www.jem.org/cgi/doi/10.1084/jem.20072390
1859
           Many autoimmune diseases, such as type I dia-
betes and multiple sclerosis, are the consequence 
of damage mediated by autoreactive T cells. 
These cells arise as a result of the stochastic pro-
cess of TCR gene rearrangement that is re-
quired to generate adequate diversity within the 
T cell pool (  1  ). Although most newly generated 
T cells are specifi  c for foreign antigens and are 
benefi  cial to the host, some display TCR with 
reactivity to self-proteins, and therefore must 
be silenced to maintain normal immunological 
homeostasis. The majority of tolerance induction 
occurs during T cell development in the thymus, 
in which T cells with strong reactivity to self-
peptide  –  MHC complexes are eliminated through 
negative selection (  2  ). Recent reports have dem-
onstrated that the transcription factor auto-
immune regulator (AIRE) mediates T cell deletion 
in the thymus through driving promiscuous ex-
pression of genes encoding many self-antigens, 
including those proteins believed to only be ex-
pressed in the periphery (  3  ). However, this pro-
cess is not entirely eff  ective, and a fraction of cells 
with specifi  city for self-antigens escape from thy-
mic negative selection. 
  The export of T cells from the thymus with 
potential reactivity to self-proteins requires the 
presence of additional tolerogenic mechanisms in 
the periphery to prevent autoimmunity. Past re-
ports have clearly demonstrated that diff  erent 
mechanisms, such as TCR down-regulation, an-
tigen-induced anergy, and regulation caused by 
FoxP3  +  CD4  +  CD25  +   T cells, may play a role in 
preventing disease induced by autoreactive T cells 
(  4  –  8  ). Additionally, tolerance can also be induced 
through cross-presentation of proteins by APC in 
the draining lymph nodes. This presentation in 
the absence of infl  ammatory signals results in T 
cell activation and subsequent removal through 
deletional tolerance (  9  –  11  ). More recently, one 
study demonstrated that in addition to its role in 
thymic selection (  3, 12  ), AIRE may also partici-
pate in maintaining peripheral tolerance. Thus, 
AIRE expression in the stromal cells of lymph 
nodes leads to antigen expression and subsequent 
deletion of T cells with potential self-reactivity 
(  13  ). These mechanisms appear to operate for T 
cells with high avidity for self-antigens, whereas 
other populations of T cells with weaker reactiv-
ity to self-antigens may persist (  14, 15  ). In the 
presence of the correct environmental cues, it is 
these T cells that may provide a potential popula-
tion required for the initiation of autoimmunity. 
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  Immune tolerance to self-antigens is a complex process that utilizes multiple mechanisms 
working in concert to maintain homeostasis and prevent autoimmunity. We developed a 
system that revealed a population of self-specifi  c CD8 T cells within the endogenous T cell 
repertoire. Immunization of ovalbumin (OVA)-expressing transgenic mice with recombinant 
viruses expressing OVA-peptide variants induced self-reactive T cells in vivo that matured 
into memory T cells able to respond to secondary infection. However, whereas the avidity of 
memory cells in normal mice increased dramatically with repeated immunizations, avidity 
maturation was limited for self-specifi  c CD8 T cells. Despite decreased avidity, such memory 
cells afforded protection against infection, but did not induce overt autoimmunity. Further, 
up-regulation of self-antigen expression in dendritic cells using an inducible system pro-
moted programmed death-1 expression, but not clonal expansion of preexisting memory 
cells. Thus, the self-reactive T cell repertoire is controlled by overlapping mechanisms 
infl  uenced by antigen dose. 
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T cells is maintained in this system, we attempted to elicit 
OVA-specifi  c cells in 232-6 mice. Infection with WT vesicular 
stomatitis virus (VSV)-OVA (designated as N4 for asparagine 
at the fourth residue) elicited few, if any, SIINFEKL-specifi  c 
CD8 T cells in 232-6 mice, but drove a robust response in WT 
mice (  Fig. 1 A  ), indicating that tolerance was being maintained.   
To attempt to reveal populations of OVA-specifi  c CD8 T 
cells in the 232-6 repertoire, we infected mice with rVSV 
expressing peptide variants of SIINFEKL in which the fourth 
position was altered from an asparagine to a glutamic acid 
(N260Q) or a leucine (N260L), termed Q4 and L4, respec-
tively. The fourth position was chosen because it has been 
determined to be a contact residue for T cell recognition and 
is not involved in MHC binding (  24  ). Remarkably, 232-6 
mice infected with VSV expressing either the Q4 or L4 vari-
ants generated populations of CD8 T cells reactive with the 
SIINFEKL-H-2K  b   tetramer (OVA-tet;   Fig. 1 A  ). Although 
the frequencies of these populations of T cells were small 
compared with the response generated by N4 infection in 
C57BL/6 mice, the overall population was approximately 
threefold greater than 232-6 mice infected with the N4 vari-
ant. Furthermore, this population expressed high levels of 
CD11a, indicating an activated phenotype, and when evalu-
ated as part of the overall CD8 population, it demonstrated 
a 5  –  8-fold increase in frequency compared with 232-6 mice 
infected with VSV-N4. As expected, all groups of mice in-
fected with the rVSV developed CD8 T cell populations spe-
cifi  c for the VSV nucleoprotein (N) epitope demonstrating 
that a productive VSV infection had occurred. These results 
indicated that immunization with Q4 or L4 variants of the 
SIINFEKL epitope generated CD8 T cells with the ability to 
recognize WT SIINFEKL peptide in transgenic animals that 
express OVA as a self-antigen. 
  We also determined the functionality of the OVA-specifi  c 
cells from rVSV-infected 232-6 mice. To do so, splenocytes 
from C57BL/6 and 232-6 mice infected with VSV-N4 or VSV-
Q4/L4, respectively, were cultured in vitro with 0.01   μ  g/ml 
SIINFEKL peptide for 4 h and evaluated for IFN-     production 
by intracellular staining (  Fig. 1 B  ). Cells from C57BL/6 mice 
immunized with control virus that lacks OVA and cells from 
232-6 mice infected with WT VSV-OVA did not produce 
detectable IFN-     upon restimulation with SIINFEKL in vitro 
(  Fig. 1 B   and not depicted). In contrast, cells from C57BL/6 
mice immunized with VSV-N4 generated a robust response, 
with     5% of the CD8 population producing IFN-    . Cells from 
232-6 mice immunized with VSV-Q4 or -L4 and restimulated 
with WT peptide also produced IFN-     (  Fig. 1 B  ). Approx-
imately 0.2  –  0.4% of the cells produced IFN-    , which correlated 
with the frequency of OVA-tet  +   cells. Interestingly, based on 
mean fl  uorescence intensities, the amount of IFN-     produced 
by Q4/L4 immunization in 232-6 mice, on a per cell basis, was 
also reduced compared with OVA-reactive cells from C57BL/6 
mice, and this diff  erence was also observed at higher peptide 
concentrations (1.0  μ  g/ml; unpublished data). Collectively, these 
data demonstrated that infection with Q4 and L4 SIINFEKL 
VSV variants resulted in the generation of an obvious, but small, 
  Although the initiating factors for autoimmunity are 
largely unknown, one hypothesis is that infection with path-
ogens expressing antigenic homologues of self-proteins may 
promote activation of potentially autoreactive T cells. For ex-
ample, pathogens such as group A streptococcus and   Borrelia 
burgdorferi   have been implicated in the initiation of myocardi-
tis and arthritis, respectively (  16, 17  ). Further, experimental 
systems have demonstrated this to occur in experimental mu-
rine models, including experimental autoimmune encephali-
tis (EAE), and suggest that infection with bacteria or viruses 
that express peptides with homology to normal self-proteins 
may initiate autoimmune diseases (  18  ). Although the exact 
mechanism is unknown, molecular mimicry is thought to 
occur through the degeneracy of the T cell receptor, where 
a TCR specifi  c for a given antigen may have weaker inter-
actions for other epitopes, including self-proteins (  19  ). This 
strategy has been used to generate T cells with specifi  cities 
against various antigens expressed by tumor cells with the 
hopes of developing therapies for the treatment of various 
malignancies. This includes immunization with xenoantigens 
such as gp100 or prostate acid phosphatase for the treatment 
of melanoma or prostate cancer, respectively (  20, 21  ). Al-
ternatively, defi  ned epitopes may be specifi  cally mutated to 
generate altered peptide ligands with the hopes of enhancing 
T cell signaling and generating T cell responses to tumor an-
tigens (  22, 23  ). 
  In this study, we demonstrate the development of self-
reactive CD8 T cells after immunization with viruses contain-
ing mutant epitopes of the chicken OVA epitope SIINFEKL 
in mice expressing OVA as a self-antigen. These self-reactive 
cells established a functional memory population in vivo  ,   
and are able to perform eff  ector functions and respond to and 
protect against secondary infection. Surprisingly, despite very 
high frequencies, autoreactivity was not evident in vivo. The 
mechanism by which these cells are kept in check is related at 
least in part to the limiting of avidity maturation after reacti-
vation. Thus, the self-reactive repertoire can exert benefi  cial 
eff  ects in the absence of autoimmunity. 
    RESULTS   
  Single amino acid SIINFEKL variants elicit OVA-specifi  c CD8 
T cells in tolerant mice 
  The ability of the immune system to prevent autoreactivity in the 
presence of T cells with specifi  cities for self-proteins requires 
the presence of potent tolerogenic mechanisms. However, 
little work has addressed tolerance induction in the endog-
enous T cell repertoire. To evaluate how tolerance is main-
tained for endogenous CD8 T cells in vivo, we used the 
232-6 transgenic mouse model, in which a truncated form of 
chicken OVA is expressed at low levels by the enterocytes of 
the small intestine (  9  ). Whereas previous studies using these 
animals and OT-I TCR transgenic T cell transfer demon-
strate that recognition of OVA as a self-protein resulted in 
deletional tolerance (  9  ), transfer in the presence of infl  amma-
tory signals results in intestinal tissue damage and weight loss 
(  9  ). Thus, to investigate how tolerance of endogenous CD8 JEM VOL. 205, August 4, 2008 
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developed CD8 T cell responses specific for SIINFEKL 
with similar kinetics to that observed for C57BL/6 mice, al-
though the overall magnitude of the response was reduced by 
    5-6-fold as compared with controls. By 40 d after infec-
tion, the memory population comprised 0.1  –  0.25% of the 
CD8 population. 
  We next examined whether the OVA-tet  +   memory cells 
could mount a secondary response to infection. Mice harbor-
ing memory cells raised by infection 40 d earlier with VSV-N4 
or -L4 were infected with recombinant   Listeria monocytogenes   
(LM)  –  expressing OVA that contains the WT (N4) epitope 
(LM-OVA;   Fig. 2, A and B  ). In control mice, tet  +   CD8 T 
cells increased by     50-fold, from 0.5 to     25% of the CD8 
population, with the peak of expansion occurring at     3 d 
after recall. Remarkably, 40 d after primary VSV-Q4 or -L4 
infection, 232-6 mice also mounted a robust recall response 
to LM-OVA challenge that was characterized by a 20  –  30-
fold increase in OVA-reactive CD8 T cells. An appreciable 
lag in the response was observed in 232-6 mice compared 
with the response in B6 mice, which is likely caused by the 
reduced number of initial antigen-specifi  c cells before chal-
lenge. In both the WT and 232-6 mice, the contraction of 
the OVA-specifi  c response was limited compared with that 
of the primary response, and thus resulted in the generation 
population of OVA-specifi  c CD8 T cells in transgenic mice that 
express OVA as a self-antigen. 
  Variant-induced, SIINFEKL-specifi  c CD8 T cells develop 
functional memory populations 
  The presence of SIINFEKL-specifi  c T cells in 232-6 OVA 
transgenic animals after VSV-Q4 or L4 immunization indi-
cated that even in the presence of abundant self-antigen, a 
primary self-specifi  c response could develop. However, it was 
possible that over time such cells would undergo deletion. 
Therefore, we examined the overall kinetics of the response 
and tested whether a self-specifi  c memory population developed. 
The latter is of particular interest, considering the apparent 
increased sensitivity of memory cells to antigenic stimulation 
(  25, 26  ). To this end, C57BL/6 and 232-6 mice were immu-
nized with VSV-N4, -Q4, -L4, or the control VSV-Indiana, 
and the percentage of SIINFEKL-reactive cells in the blood 
was evaluated over time (  Fig. 2, A and B  ).   C57BL/6 mice 
immunized with VSV-N4 mounted a robust OVA-specifi  c 
response that peaked 7 d after infection with     6% of the 
CD8 population staining brightly with OVA-tet. This was 
followed by a contraction phase such that by 40 d after infec-
tion,     0.5% of the CD8 population remained OVA-tet pos-
itive. 232-6 mice immunized with either VSV-Q4 or -L4 
    Figure 1.     Q4 and L4 SIINFEKL variants elicit cross-reactive T cell responses in 232-6 mice.   (A) C57BL/6 and 232-6 OVA transgenic mice were 
immunized with rVSV expressing the N4, Q4, or L4 variants of the SIINFEKL epitopes. 7 d later, splenocytes were evaluated for N-tet –   (left)  and  OVA-tet –
 specifi  c (middle) T cell populations. CD8  +   T cells were also evaluated for the coexpression of OVA-tet and CD11a (right). (B) IFN-     expression by OVA-reac-
tive T cells. C57BL/6 and 232-6 mice were immunized with VSV-N4, Q4, and L4. 7 d later, splenocytes were restimulated in culture for 4 h with SIINFEKL 
peptide and evaluated for intracellular IFN-     expression. The percentage of CD11a  hi IFN-   +   cells among CD8 T cell is indicated in the top right of the dot 
plot. Data are representative of three animals/group.     1862 INDUCTION OF SELF-SPECIFIC MEMORY CD8 T CELLS   | Turner et al. 
of a substantial pool of secondary memory cells (  Fig. 2 B  ). 
Thus, self-specifi  c CD8 T cells persisted long term without 
a signifi  cant loss of cells. In addition, despite the presence of 
large numbers of OVA-reactive CD8 T cells during and after 
the recall response in 232-6 mice, the gross morphology of the 
intestinal mucosa remained normal and weight loss did not 
occur (unpublished data). 
  The previous experiment demonstrated that VSV-Q4 and 
-L4 immunization can produce a population of OVA-specifi  c 
T cells with characteristics of memory cells, including the 
ability to persist long term and respond to secondary infec-
tion. To determine whether any phenotypic distinctions were 
evident between OVA-specifi  c memory cells in 232-6 and 
C57BL/6 mice, we evaluated expression of CD11a, CD62L, 
and IL-7R. The phenotype of memory cells from either source 
was similar, as follows: CD11a  hi  , CD62L  lo  , and IL-7R  hi   (  Fig. 
2 C  ). These data suggested that the 232-6  –  derived memory cells 
were not chronically stimulated with antigen because they 
expressed high levels of IL-7R     (  27  ). This was also true of the 
limited numbers of OVA-tet  +   cells found in the intestinal 
mucosa (unpublished data). A subset of CD62L  hi   central mem-
ory cells (  28, 29  ) was also detected in both groups, indicating 
that a bias toward a particular memory subset did not occur as 
the result of self-antigen expression. 
  OVA-reactive CD8 T cells exhibit lytic activity in vivo 
  OT-I cells activated by infection induce intestinal epithelial 
cell damage in 232-6 mice (  9  ) resulting in weight loss. The 
fi  nding that the endogenous self-specifi  c CD8 T cells resi-
dent in 232-6 mice did not cause obvious intestinal damage 
suggested a state of anergy. Although the primary OVA-tet  +   
cells produced cytokines (  Fig. 1  ), it was possible that longer-
term exposure to antigen-induced functional abnormalities. 
Therefore, we tested the in vivo lytic activity of the OVA-
reactive cells at the peak of the recall response when autoim-
mune activity might be expected (  Fig. 3  ).   Previously infected 
WT or 232-6 mice were challenged with LM-OVA and, 5 d 
later, peptide-coated, CFSE-labeled target cells were injected. 
4 h later, spleen cells were evaluated for the presence or ab-
sence of target cells. As expected, high levels of lytic activity 
against VSV nucleoprotein N peptide  –  coated cells, but little 
lysis of the unpulsed targets, was detected in all mice (  Fig. 3  ). 
Conversely, SIINFEKL-specifi   c lysis was not observed in 
those animals that were only immunized with VSV-Indiana, 
but robust activity was demonstrated in mice after immuniza-
tion with the VSV-N4  –  positive control. Interestingly, 232-6 
mice immunized with either VSV-Q4 or -L4 also demon-
strated lysis of the SIINFEKL-pulsed target cells (  Fig. 3  ). 
Although killing levels were less than that of the positive 
control, it should be noted that this result directly correlated 
with the reduced frequencies of OVA-reactive cells in 232-6 
mice. Nevertheless, it remains possible that cells in the 232-6 
    Figure 2.         Kinetics and phenotype of OVA-reactive CD8 T cells in 
232-6 and C57BL/6 mice.   (A) C57BL/6 and 232-6 mice were immu-
nized with control VSV-Indiana or VSV containing the N4, Q4, or L4 
SIINFEKL epitopes. 40 d later, N4-, Q4-, and L4-immunized mice were 
challenged with 10  3   LM-OVA. All animals were bled periodically during the 
primary and secondary responses to monitor OVA-tetramer  +   CD8 T cells. 
(B) Kinetic analysis of OVA-reactive CD8 T cells in C57BL/6 and 232-6 
mice immunized with VSV-N4 (    ) or L4 (    ), respectively, and then 
rechallenged with LM-OVA as described in A (three animals/group). 
(C) Memory markers were evaluated on OVA-specifi  c splenocytes 40 d 
after recall. Open histograms, CD11a  hi ,  OVA-tet +   cells; dark histograms, 
CD11a  lo   naive  cells.   
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(i.e., not expressing OVA) was used to challenge previously 
infected B6 or 232-6 mice, showed that the protection ob-
served was antigen-specifi  c and not the result of nonspecifi  c 
innate immunity (unpublished data). Collectively, these re-
sults indicate that the OVA-specifi  c T cells in 232-6 mice 
are able to protect against LM-OVA infection. Although 
the overall reduction in 232-6 mice is lower than that ob-
served in C57BL/6 mice, this was likely attributable to the 
presence of reduced numbers of OVA-reactive cells in 232-6 
mice (  Fig. 4 C  ). 
  T cell avidity maturation is limited in 232-6 mice 
  The level of tetramer staining of primary OVA-specifi  c CD8 
T cells in 232-6 mice raised by VSV-Q4/L4 infection suggested 
mice exhibited reduced lytic activity on a per cell basis com-
pared with those from WT mice. 
  Self-specifi  c CD8 T cells protect against LM-OVA infection 
  Because OVA-reactive cells in 232-6 mice performed eff  ec-
tor functions, we next evaluated their ability to protect against 
high-dose LM-OVA infection (  Fig. 4  ).   C57BL/6 and 232-6 
mice were immunized with VSV-N4 or -Q4, respectively. 
Both groups of mice were infected 30 d later with vaccinia 
virus (VV)  –  expressing OVA (VV-OVA) to expand the number 
of OVA-reactive cells while concurrently preventing responses 
to endogenous LM antigens. Immunized and nonimmunized 
animals were challenged with 2   ×   10  5   LM-OVA, and 3 d 
later, bacterial burdens in the spleen and liver were enumer-
ated. Naive C57BL/6 and 232-6 mice challenged with LM-
OVA presented high bacterial counts in both the spleen and 
liver (  Fig. 4, A and B  ). Conversely, immunized C57BL/6 
mice were eff  ectively protected, with virtually all LM-OVA 
cleared within the 3-d period. Importantly, 232-6 mice initially 
infected with VSV-Q4 and recalled with VV-OVA demon-
strated a significant level of protection in the spleen and 
partial protection in the liver. Although less than that ob-
served for C57BL/6 mice, 232-6 mice demonstrated a 3 log 
reduction in the spleen (P   <   0.0001) and 1 log reduction 
for the liver (P = 0.037) when compared with uninfected 
control groups. Additional control studies in which WT LM 
    Figure 3.     Q4- and L4-induced OVA-specifi  c T cells demonstrate 
reduced lytic activity in vivo.   C57BL/6 and 232-6 mice were infected 
with control VSV-Indiana or rVSV expressing the N4, Q4, or L4 variant 
SIINFEKL epitopes. 30 d later, animals were challenged with 10  3   LM-OVA. 
5 d later, animals were injected with congenically disparate splenocytes 
labeled with CFSE (2, 0.2, and 0.02   μ  M) and pulsed with SIINFEKL (shaded) 
or N-peptide (open). Percentage of killing was evaluated 4 h later in the 
spleen. Error bars indicate the SEM of three animals/group.     
    Figure 4.         OVA cross-reactive T cells protect against LM-OVA 
challenge.   C57BL/6 and 232-6 mice were immunized with rVSV-N4 
or -Q4, respectively, and recalled 30 d later with VV-OVA. 30 d after 
recall, mice were challenged with 2   ×   10  5   LM-OVA, and after 3 d, the 
number of LM-OVA CFU in the spleen (A) and liver (B) were evaluated. 
(C) Splenic OVA-reactive CD8 T cells were also evaluated for each group 
by OVA-tet staining. Data are representative of three to fi  ve mice/group. 
*, P   <   0.0001; **, P = 0.037. Error bars represent the SEM of three to fi  ve 
mice/group.   1864 INDUCTION OF SELF-SPECIFIC MEMORY CD8 T CELLS   | Turner et al. 
ondary memory cells and further increased to a remarkable 
30 min after tertiary immunization. By comparison, naive 
OT-I TCR Tg cells that are used extensively in autoimmu-
nity models and cause intestinal disease in 232-6 mice (  9  ), 
displayed a T  1/2   of 13 min, a value intermediate between sec-
ondary and tertiary endogenous memory cells. 
  For primary OVA-reactive cells from 232-6 mice, a T  1/2   
of   <  1 min was determined. Nevertheless, avidity maturation 
did occur after secondary infection of 232-6 mice, with sec-
ondary memory cells exhibiting a T  1/2   of     3 min, a value not 
statistically signifi  cantly diff  erent than that obtained for pri-
mary WT cells. However, in stark contrast to events in WT mice, 
tertiary immunization did not result in an increase of avidity 
in 232-6 mice, with the T  1/2   remaining at     3 min, despite a 
substantial increase in total antigen-specifi  c CD8 T cells (  Fig. 
5 B   and not depicted). Collectively, these data suggested that 
self-antigen limits avidity maturation of the memory popu-
lation by elimination or negative regulation of high-avidity 
clones in the naive repertoire. 
  Self-specifi  c memory CD8 T cells retain the ability 
to recognize self-antigen 
  The previous experiments suggested that CD8 T cell toler-
ance in 232-6 mice was maintained by reduced TCR avidity, 
which limited avidity maturation of responding cells. Never-
theless, such cells mounted a robust response to antigen pre-
sented in the context of infection. Thus, it remained unclear 
why the OVA-specifi  c cells in 232-6 mice did not exhibit 
apparent signs of antigen experience. Either these cells were 
refractory to self-antigen presentation or antigen levels were 
insuffi   cient to drive activation. This may be of particular 
importance in situations where antigen levels increase over 
time, such as with developmental proteins or tumor-asso-
ciated antigens. To evaluate this possibility, we developed 
a transgenic mouse line in which SIINFEKL expression could 
be regulated in CD11c  +   cells upon treatment with doxycycline 
(CD11c-rtTA/tetO-pMinCMV-SED [SED-rtTA]). To com-
pare antigen levels in SED-rtTA mice to the levels in 232-6 
mice, we performed transfers with CFSE-labeled OT-I cells. 
In the absence of doxycycline treatment of SED-rtTA mice, 
adoptively transferred CFSE-labeled naive OT-I T cells under-
went minimal division in the mesenteric lymph nodes after 5 d 
in vivo (  Fig. 6 A  ).   In contrast, treatment with doxycycline 
for 5 d before OT-I transfer resulted in robust expansion of 
OT-I cells to     5% of the total lymphocytes, confi  rming the 
inducibility of the system. Expansion of OT-I cells in 232-6 
mice was substantially less than that observed in induced SED-
rtTA mice, with OT-I cells comprising   <  1% of the popula-
tion ( Fig. 6 A ). This result indicated that 232-6 mice expressed 
lower levels of antigen than doxycycline-treated SED-rtTA 
mice, which allowed us to test the eff  ect of increased antigen 
expression by all CD11c  +   cells. 
  Even in the absence of doxycycline induction, SED-rtTA 
mice do not mount an endogenous OVA-specifi  c CD8 T 
cell response, indicating that   “  leakage  ”   in the system allows 
tolerance induction similar to that observed in 232-6 mice. 
that these cells were of lower avidity compared with control 
CD8 T cells. However, the level of tetramer staining for sec-
ondary memory cells in 232-6 mice appeared similar to that 
of OVA-specifi  c cells from WT mice (  Fig. 2 C  ), which is in 
agreement with a previous study showing that avidity matu-
ration of the eff  ector CD8 T cell population occurs after sec-
ondary infection (  30  ). Nonetheless, tetramer staining by itself 
is an inaccurate measure of TCR avidity (  31  ). To more pre-
cisely compare the avidity maturation of self-specifi  c CD8 T 
cells in 232-6 and WT mice, we used a tetramer binding/ 
decay assay that allows comparisons of apparent dissociation 
rates between populations by measuring the time required to 
reach 50% of maximal tetramer binding (T  1/2  ) (  31  ). Primary, 
secondary, and tertiary OVA-specifi  c memory CD8 T cells 
from WT and 232-6 mice were analyzed. OVA-specifi  c T cells 
from the primary response in C57BL/6 mice exhibited a T  1/2   
of     3.5 min (  Fig. 5  ).   This value increased to     5 min for sec-
    Figure 5.         OVA cross-reactive T cells undergo limited avidity matu-
ration in vivo.   (A) Tetramer decay on OVA-reactive T cells from tertiary 
immunization of 232-6 mice immunized initially with VSV-Q4 (   ), 
C57BL/6 mice immunized with VSV-N4 (    ), and naive OT-I T cells (   ). 
Also included are 232-6  –  derived T cells in the absence of Y3 Fab frag-
ments (    ). (B) Avidity maturation of OVA-reactive T cells in 232-6 and 
C57BL/6 mice after multiple immunizations. Tetramer decay analysis was 
evaluated 7 d after primary immunization. 30 d after secondary recall 
with VV-OVA and 30 d after tertiary immunization with LM-OVA. Naive 
OT-I (N) were also tested by decay analysis. Error bars indicate the SEM of 
values from three animals/group. P values are shown for the indicated 
comparisons.   JEM VOL. 205, August 4, 2008 
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or deletion of the OVA-specifi  c population. However,     40% 
of OVA-reactive T cells in doxycycline-treated, but not in 
untreated, mice expressed increased levels of the negative 
regulator PD-1, indicating that antigen-recognition had oc-
curred (  Fig. 6 D  ). Thus, with increased antigen levels, low-
avidity self-reactive memory CD8 T cells were able to sense 
antigen, but, at least in the short-term, they were not deleted; 
instead, they were perhaps negatively regulated by PD-1  –
  PDL1 interactions. 
    DISCUSSION   
  Although the T cell repertoire is believed to be largely purged 
of autoreactive cells via central tolerance during thymic 
Just as with 232-6 mice, however, infection with VSV-Q4 
reveals a population of endogenous OVA-specifi  c CD8 T 
cells that are able to respond to LM-OVA challenge (  Fig. 6 B  , 
middle). We then tested whether such cells could respond to 
the increased antigen levels present in doxycycline-induced 
SED-rtTA mice. 30 d after secondary infection, LM-OVA 
SED-rtTA mice were fed doxycycline for 7 d, and the OVA-
reactive cells were then quantifi  ed in the peripheral blood. 
No change in the overall frequencies of OVA-reactive cells 
in the blood or in the total numbers of OVA-specifi  c cells in 
the spleen was observed in doxycycline-fed mice compared 
with untreated mice (  Fig. 6 C  ). These data indicated that ele-
vated self-antigen expression did not result in overt expansion 
    Figure 6.         OVA cross-reactive memory T cells up-regulate PD-1 in response to self-antigen expression by dendritic cells.   (A) Comparison of 
SED-rtTA and 232-6 transgenic mice. SED-rtTA mice were treated with or without 10 ng/ml of doxycycline for 7 d. Both groups of SED-rtTA and 232-6 
mice were transferred with 5   ×   10  5   CFSE-labeled OT-I T cells and evaluated for proliferation in the mesenteric lymph nodes 5 d later. CFSE dilution of 
transferred OT-I is indicated in the histograms (top) and the percentage of OT-I T cells of total lymphocytes is shown below. (B) SED-rtTA mice were 
immunized with VSV-N4 (left) or VSV-Q4 (middle) and evaluated for the presence of OVA-reactive CD8 T cells in the peripheral blood 7 d later. Mice immu-
nized with VSV-Q4 and infected with LM-OVA 35 d later were evaluated for OVA-reactive cells 5 d later (right). (C) CD11c-inducible transgenic mice were 
immunized with VSV-Q4, and 30 d later, they were recalled with 10  3   LM-OVA. 30 d after recall, mice were bled and before and 5 d after treatment with or 
without 10 ng/ml of doxycycline. (top) Levels of OVA-specifi  c T cells were normalized to preinduction levels. (bottom) Total numbers of OVA-specifi  c T 
cells were enumerated in the spleen 5 d after induction. (D) PD-1 staining on CD8  + ,  OVA-tetramer +   lymphocytes isolated from the spleen of VSV-Q4 and 
LM-OVA boosted SED-rtTA mice. Black histogram indicates PD-1 level in untreated and gray histogram indicates the level in doxycycline treated mice. 
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TCR avidity is an enhanced risk of cross-reactivity with self-
antigens. In 232-6 mice, an apparent   “  avidity ceiling  ”   existed 
for OVA-reactive TCR that was likely based on the level of 
antigen needed intra- or extrathymically to drive negative 
selection and thereby maintain tolerance. 
  The level of self-antigen, the avidity of autoreactive T cells, 
and the susceptibility of the target organ to autoimmune dam-
age all play important roles in whether autoimmunity is man-
ifested. Indeed, the low avidity of self-specifi  c CD8 T cells 
does not preclude the ability of these cells from recognizing 
self-antigen in vivo and either clearing tumors or inducing 
autoimmunity. For example, a recent study demonstrated that 
crossing transgenic mice expressing a fi  xed     -chain TCR 
(derived from the OT-I TCR) with RIP-mOVA animals 
expressing membrane-bound OVA in the pancreas results 
in loss of high-avidity, OVA-specifi  c CD8 T cells, but does 
not prevent diabetes after infection with LM-OVA (  37  ). Al-
though the overall avidity of these cells is considered low 
compared with fi  xed     -chain cells that have not developed in 
the presence of antigen, comparisons with endogenously de-
rived T cells have not been performed. One might speculate 
that because of expression of the     -chain, these low-avidity 
T cells may recognize antigen with a higher avidity than 
endogenous T cells that have developed under tolerogenic 
conditions. In addition, the pancreas may be more sensitive 
to autoimmune damage compared with, for example, the 
intestine, which may be more resilient, thereby requiring a 
more substantial autoreactive insult to exhibit disease. Thus, 
although avidity is important in the maintenance of toler-
ance, other mechanisms must also be involved. 
  Of what functional signifi  cance are low-avidity T cells? 
In our system, low-avidity, self-specifi  c memory cells pro-
vided protection against infection, despite exhibiting unde-
tectable autoreactivity. Additionally, in the aforementioned 
transgenic systems, low-avidity CD8 T cells are able to reject 
tumors (  32, 38  ). Thus, low-avidity T cells may have pro-
tective capabilities, but retain a reduced capacity for auto-
reactivity. This scenario may be the result, at least in part, of 
regulation of reactivity by antigen dosage. In our system, self-
specifi  c memory cells showed no obvious signs of antigen 
recognition unless confronted with a pathogen expressing 
their cognate antigen or with DCs expressing high levels of 
antigen. In the former case, expansion occurred, whereas in 
the latter, up-regulation of programmed death-1 in the ab-
sence of expansion or deletion of the population was the out-
come, at least in the relatively short time frame studied (7 d). 
It should be noted, however, that high-avidity naive cells re-
sponded with robust proliferation within this time period. 
These results suggested that infl   ammation, and likely in-
creased antigen levels, were driving activation after infection, 
whereas in the absence of infl  ammation, PD-1 was up-regu-
lated, thereby limiting expansion. The latter remains to be 
tested, but is in agreement with recent studies regarding neg-
ative regulation of T cell expansion (  39  ). The ability of low 
avidity T cells to respond to antigen may play an important 
role in circumstances in which antigen levels increase in vivo, 
  selection, this mechanism is not fully eff  ective, and cells ex-
pressing TCR specifi  c for self-antigens are present in the 
periphery. However, the peripheral endogenous self-reactive 
repertoire has not been analyzed in detail, largely because of 
the paucity of such cells. Thus, TCR transgenic T cells with 
clonal single-avidity TCR have been used in many cases to 
study T cell selection and peripheral tolerance. These systems 
have revealed much regarding the mechanisms governing T 
cell tolerance induction; nevertheless, the results need to be 
considered in light of analyses of endogenous T cells. In our 
system, in which high-avidity CD8 T cell clones are absent 
or nonresponsive, as indicated by the lack of a response to 
virally expressed cognate antigen, infection with virus-en-
coded peptide variants revealed a population of self-specifi  c, 
low-avidity CD8 T cells. In comparison, primarily low-avid-
ity CD8 T cells specifi  c for infl  uenza virus hemagglutinin or 
nucleoprotein, are present in mice expressing hemagglutinin 
in the pancreas (Ins hemagglutinin mice) (  14, 32  ) or nucleo-
protein ubiquitously (  33  ), respectively, suggesting that the 
escape of such clones from deletion or negative regulation is 
a hallmark of tolerance induction. However, in some cases 
high avidity self-reactive clones may also be retained, and, 
under certain circumstances, may be responsible for autoim-
munity, but they can also be exploited for tumor immuno-
therapy (  34, 35  ). 
  Our results also addressed the issue of CD8 T cell avidity 
maturation in the presence or absence of a constitutively ex-
pressed   “  neo-self  ”   antigen. Whereas previous reports mea-
sured the sensitivity of TCR triggering by varying peptide 
concentrations to assess avidities, we used tetramer binding 
decay with anti-MHC blocking using Fab fragments to de-
termine the half-life of peptide  –  MHC  –  TCR complexes (  31  ). 
This technique has the advantage of providing a more specifi  c 
measurement of peptide  –  MHC  –  TCR interactions without 
measuring potential diff  erences in co-stimulation or restruc-
turing of signaling components that might infl  uence functional 
assays (  36  ). Of considerable interest was the fi  nding that al-
though a signifi  cant increase in avidity occurred between pri-
mary and secondary responses (as previously suggested [  30  ]), 
a much greater avidity increase was detected after tertiary im-
munization. Whether this is a general feature of tertiary im-
munization or is related to epitope specifi  city or immunization 
regimen will require further studies, but nevertheless, it indi-
cated the utility of additional boosting to enhance vaccina-
tion. In the case of 232-6 mice, whereas primary OVA-specifi  c 
CD8 T cells were of very low avidity, after secondary immu-
nization, the avidity of the OVA-specifi  c CD8 T cell popu-
lation increased to the level of CD8 T cells in the primary 
response of normal mice. Tertiary immunization, however, 
did not result in a further avidity increase, indicating that ei-
ther the high-avidity clones had been deleted centrally and/
or peripherally or were somehow suppressed. Teleologically, 
the ability of the CD8 T cell repertoire to   “  focus  ”   toward in-
creasingly higher avidities in response to repeated infections 
or vaccinations is, at least in part, one basis for more eff  ective 
protection. However, one potential consequence of increased JEM VOL. 205, August 4, 2008 
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cells were removed at various time points and immediately fi  xed in 2% para-
formaldehyde/PBS. The half-life of tetramer binding was determined by 
normalizing the mean fl  uorescence intensity of each time point to the zero 
time point control. The time taken to reach one half of the fl  uorescence 
  intensity of the control (zero time point) was determined to be the relative 
avidity of each population. 
  Protection assay.     232-6 and C57BL/6 mice were immunized with 10  6   
PFU rVSV encoding the tOVA-GFP fusion construct or Q4 and L4 variants 
i.v. 30 d later, animals were rechallenged with 5   ×   10  6   PFU recombinant VV 
encoding chicken OVA (VV-OVA), which was provided by J. Yewdell 
(National Institutes of Health, Bethesda, MD). 30 d later, immunized and 
unimmunized animals were challenged with 2   ×   10  5   CFU LM expressing 
chicken OVA (LM-OVA), as previously described (  45  ). 3 d later, the spleen 
and liver were evaluated for the presence of LM by dissociation of tissues 
through a 40-  μ  m fi  lter with 1% saponin in PBS. Dilutions of each tissue were 
inoculated onto brain  –  heart infusion agar plates containing 1   μ  g/ml strepto-
mycin, and the number of colonies was enumerated 48 h later. 
  In vivo killing assay.     In vivo killing was performed as previously de-
scribed, with slight modifi  cations (  46  ). Splenocytes from CD45.1 B6 mice 
were stained with 2   μ  m, 0.2   μ  m, or 0.02   μ  m of CFSE, followed by incubation 
with 1   μ  g/ml of VSV N peptide (RGYVYQGL), SIINFEKL (N4) peptide, 
or PBS, respectively, for 30 min at 37  °  C. N4 is the WT SIINFEKL sequence. 
Equal numbers of each target population were mixed and injected i.v. into 
CD45.2 B6 mice that were naive or had been infected as indicated in the 
fi  gure legend. 4 h later, recipient mice were evaluated for the presence of 
CFSE-labeled target cells in the spleen. Percent specifi  c lysis was determined 
by the following equation: 100      ([Immunized percentage of N4-pulsed 
target/Immunized percentage unpulsed target] / [Unimmunized percentage 
N4 pulsed target/Unimmunized unpulsed target]   ×   100). 
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